India – Examining The Regulatory And Operational Issues Affecting M&A In Pharmaceuticals And Healthcare Industry.

- Bishwajit Dubey - Partner, Cyril Amarchand Mangaldas

India – SEBI Issued A Circular On Operational Guidance – Amendment To Securities And Exchange Board Of India (Buy-Back Of Securities) Regulations, 2018 (“Buy-Back Regulations”).

- Vineet Aneja - Clasis Law,

India – SEBI Issued A Master Circular For Foreign Venture Capital Investors (FVCIs).

- Vineet Aneja - Clasis Law,

India – Cyril Amarchand Mangaldas Advises The Placement Agents In Relation To The Sale Of Shares Of Interglobe Aviation By Shobha Gangwal.

India – Cyril Amarchand Mangaldas Advises Goldman Sachs On Bulk Trade In Dabur.

AKP Handbook on Changing Paradigms of FEMA in India.

- Anuroop Omkar - AK & Partners,

India – AKP Banking & Finance Digest- March 20, 2023.

- Anuroop Omkar - AK & Partners,

India – Fresh Look Needed For Re-Classification Of Promoters.

India – HBO’s Succession: Reel-To-Real Life Lessons For Indian Family Businesses.

India – Section 79 Cannot Be Invoked When There Is No Change In Ultimate Beneficial Shareholding.

Counterfeit Medicines And Health Products Are Rampant In Southeast Asia.

India – Cyril Amarchand Mangaldas Advises J.P. Morgan On INR 1612 Cr Block Trade In Samvardhana Motherson International